Navigation Links
CellCyte Genetics Corp. Appoints Tony Colasin as Director of Business Development
Date:11/16/2007

FOR ITS RESEARCH AND DEVELOPMENT ACTIVITIES. THERE CAN BE NO ASSURANCE THAT THE COMPANY'S DEVELOPMENT EFFORTS WILL SUCCEED AND THE COMPANY WILL ULTIMATELY ACHIEVE COMMERCIAL SUCCESS.

THESE FORWARD-LOOKING STATEMENTS ARE MADE AS OF THE DATE OF THIS NEWS RELEASE, AND THE COMPANY ASSUMES NO OBLIGATION TO UPDATE THE FORWARD-LOOKING STATEMENTS, OR TO UPDATE THE REASONS WHY ACTUAL RESULTS COULD DIFFER FROM THOSE PROJECTED IN THE FORWARD-LOOKING STATEMENTS. ALTHOUGH THE COMPANY BELIEVES THAT THE BELIEFS, PLANS, EXPECTATIONS AND INTENTIONS CONTAINED IN THIS NEWS RELEASE ARE REASONABLE, THERE CAN BE NO ASSURANCE THOSE BELIEFS, PLANS, EXPECTATIONS OR INTENTIONS WILL PROVE TO BE ACCURATE. INVESTORS SHOULD CONSIDER ALL OF THE INFORMATION SET FORTH HEREIN AND SHOULD ALSO REFER TO THE RISK FACTORS DISCLOSED IN THE COMPANY'S PERIODIC REPORTS FILED FROM TIME-TO- TIME WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION. THIS NEWS RELEASE HAS BEEN PREPARED BY MANAGEMENT OF THE COMPANY WHO TAKE FULL RESPONSIBILITY FOR ITS CONTENTS. EACH OF THE NASD, THE SEC AND THE OTCBB NEITHER APPROVES NOR DISAPPROVES OF THE CONTENTS OF THIS NEWS RELEASE. THIS NEWS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.


'/>"/>
SOURCE CellCyte Genetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Genetics Hold Promise, Challenges for Cancer Care
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Salugen to Present Research on Generational Associations of Reward Deficiency Syndrome at XVth World Congress on Psychiatric Genetics
4. Obesity genetics
5. The genetics of MLL leukemogenesis
6. Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting
7. Clarient Names Michele Hibbard, Ph.D. Director of Genetics
8. Response Genetics Announces Presentation/Webcast at BIOCOM Investor Conference
9. Interleukin Genetics to Host Third Quarter 2007 Financial Results Conference Call November 7
10. Response Genetics to Announce Third Quarter 2007 Financial Results on Wednesday, November 14, 2007
11. Response Genetics Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... (HealthDay News) -- Astronauts may be at heightened ... human immune systems, a new study suggests. That ... to asteroids, the moon and Mars undertaken in the ... space can be dangerous, NASA researchers say. They ... blood of International Space Station crew members remains relatively ...
(Date:8/29/2014)... 29, 2014 (HealthDay News) -- If you have bunions, taking ... treatment later, an expert says. A bunion is a ... when bone or tissue moves out of place and extends ... can cause debilitating pain and may require surgery to correct, ... Medical Center in Freehold, N.J. To prevent bunions, avoid ...
(Date:8/29/2014)... Elk Grove Village, IL (PRWEB) August 29, 2014 ... an innovator in hearing wellness solutions, is on its ... Sept. 15-17 at the San Diego Convention Center to ... for those who work in high-noise industrial environments. Etymotic’s ... among the hottest wearable technology devices at the show. ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 LiveOps, Inc., ... service solutions, today announced that LiveOps has been selected ... Association's (MDA) Show of Strength Telethon for the third ... raises money and awareness to support MDA’s mission to ... aggressive and sometimes fatal muscle disease. This year’s program ...
(Date:8/29/2014)... FRIDAY, Aug. 29, 2014 (HealthDay News) -- Prostate cancer ... good treatment decisions. This can lead to worse quality ... The study included 70 men, with a median age ... cancer. Poor understanding of the disease was associated ... less confidence that the treatment would be effective, the ...
Breaking Medicine News(10 mins):Health News:Spaceflight Might Weaken Astronauts' Immune Systems 2Health News:Take Steps to Control Bunions 2Health News:Etymotic’s Safe Listening Earphones and Earplugs Headed For The 2014 NSC Safety Expo 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4Health News:Faced With Prostate Cancer, It Helps to Know the Enemy 2
... ... coverage of anti-aging supplements has created a brand new market for health supplements, customers ... has garnered special attention, HGH Supplements like Sytropin. , ... (PRWEB) February 23, 2010 -- Increased positive coverage ...
... ... for training coders, admins, techs, and nurses through online continuing education. , ... Fort Lauderdale, FL (PRWEB) February ... has developed online continuing education programs for nurses , human resources administrators, and ...
... , ... ... ... ...
... ... ... ... ...
... February 23, 2010 Researchers from The George Washington University, ... that asthma, a largely manageable and chronic disease, is on ... magnitude of the asthma crisis, the surging cost of treatment, ... are uninsured. A new report from GW, Changing pO2licy: ...
... condition that leads to severe physical and mental deterioration, psychiatric ... to slow down or stop it. HD sufferers are ... until late in life. In a new study published ... Fabiola Ribeiro of Robarts Research Institute at The University of ...
Cached Medicine News:Health News:Sytropin HGH Shows Promising Anti-Aging Results 2Health News:Kaplan Continuing Education Expands Health Care Certificate Programs 2Health News:Kaplan Continuing Education Expands Health Care Certificate Programs 3Health News:ChildCare Education Institute Supports the First Lady's Efforts to Reduce Childhood Obesity 2Health News:ChildCare Education Institute Supports the First Lady's Efforts to Reduce Childhood Obesity 3Health News:ChildCare Education Institute Supports the First Lady's Efforts to Reduce Childhood Obesity 4Health News:ChildCare Education Institute Supports the First Lady's Efforts to Reduce Childhood Obesity 5Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 2Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 3Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 4Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 5Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 6Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 7Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 8Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 9Health News:Startling new childhood asthma data 2Health News:Startling new childhood asthma data 3Health News:Startling new childhood asthma data 4Health News:Protecting the brain from of a deadly genetic disease 2
(Date:8/29/2014)... Research and Markets  has announced the addition of the ... to their offering. The Central Nervous System ... segments of pharmaceuticals industry. The numbers of CNS disorders have ... unable to meet the market requirements. There has been steady ... over the past two decades. The market for CNS therapies ...
(Date:8/29/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ... the District of New Jersey ... against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... that U.S. Patent No. 6,765,117 is both valid and ... its generic product until the expiration of that patent ...
(Date:8/29/2014)... -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS ... release its financial results for the fiscal 2014 fourth ... trading ends on Tuesday, September 9, 2014. ... p.m. U.S. EDT on Tuesday, September 9, 2014 (Wednesday, ... Company,s financial results, commercial partnerships, and future outlook.  The ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
... , June 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... announced today that it,will hold its 2010 Annual Meeting of Shareholders ... Beijing Time. The meeting will be held concurrently at No. 39,Shangdi ... 6 Temple Street, St.,John,s, Antigua . All shareholders of record ...
... The chairman of the U.S. bishops, Committee on Pro-Life Activities ... over its move toward approving a new drug that may induce ... letter to Dr. Margaret Hamburg , Commissioner of the ... criticized the FDA,s move to hold an advisory committee meeting ...
Cached Medicine Technology:Sinovac Schedules 2010 Annual Meeting of Shareholders 2Sinovac Schedules 2010 Annual Meeting of Shareholders 3Pro-Life Chair Voices 'Grave Concern' over FDA Plan to Approve Abortion Drug for 'Emergency Contraception' 2Pro-Life Chair Voices 'Grave Concern' over FDA Plan to Approve Abortion Drug for 'Emergency Contraception' 3Pro-Life Chair Voices 'Grave Concern' over FDA Plan to Approve Abortion Drug for 'Emergency Contraception' 4
... The IMMULITE 2000, a continuous ... throughput of 200 tests per hour, ... efficiency and consolidation in medium- and ... package, with its self-explanatory graphical user ...
AIA - Nex.IA immunoassay analyzer state of the art automation and flexibility for high throughput immunoassay testing...
The FastPack system is a state of the art, lab quality immunoassay system designed for rapid results. The FastPack system delivers lab-quality sensitivity at a fraction of the cost of laboratory....
... The Vitros 950 provides ... the needs of high volume ... of up to 900 results ... can store and perform the ...
Medicine Products: